KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Diebold Nixdorf (DBD) Capital Expenditures (2016 - 2025)

Diebold Nixdorf's Capital Expenditures history spans 17 years, with the latest figure at $7.0 million for Q4 2025.

  • For Q4 2025, Capital Expenditures rose 45.83% year-over-year to $7.0 million; the TTM value through Dec 2025 reached $24.3 million, up 15.17%, while the annual FY2025 figure was $24.3 million, 5.65% up from the prior year.
  • Capital Expenditures reached $7.0 million in Q4 2025 per DBD's latest filing, up from $6.2 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $10.4 million in Q3 2021 to a low of $1.7 million in Q1 2025.
  • Average Capital Expenditures over 5 years is $6.5 million, with a median of $6.2 million recorded in 2024.
  • Peak YoY movement for Capital Expenditures: surged 225.0% in 2021, then crashed 72.58% in 2025.
  • A 5-year view of Capital Expenditures shows it stood at $9.5 million in 2021, then crashed by 50.53% to $4.7 million in 2022, then decreased by 21.28% to $3.7 million in 2023, then grew by 29.73% to $4.8 million in 2024, then surged by 45.83% to $7.0 million in 2025.
  • Per Business Quant, the three most recent readings for DBD's Capital Expenditures are $7.0 million (Q4 2025), $6.2 million (Q3 2025), and $9.4 million (Q2 2025).